Heba Nabil Ali Abdelmegeed

Dr. Heba Nabil Ali Abdelmegeed

Chemistry of natural compounds, National Research Center, Giza, Al Jīzah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2024 in Molecules
Verified
Journal Article
Open access
PDF file
EEEslam El-Sawy
Eslam El-Sawy
MAMohamed S. Abdel-Aziz
Mohamed S. Abdel-Aziz
HAHeba Nabil Ali Abdelmegeed
Heba Nabil Ali Abdelmegeed
Gilbert KirschGilbert Kirsch
Gilbert Kirsch
Quorum sensing (QS) is a bacterial cell-to-cell communication mechanism that plays an essential role in bacterial pathogenesis. QS governs bacterial behavior and controls biofilm formation, which in turn contributes to antibiotic resistance. Therefore, identifying and synthesizing novel compounds to overcome QS and inhibit biofilm formation are essential. Coumarins are important plant-derived natural products with wide-ranging bioactivities and extensive applications, including antibacterial, antifungal, anticoagulant, antioxidant, anticancer, and anti-inflammatory properties. Additionally, coumarins are capable of QS rewiring and biofilm formation inhibition, leading to higher susceptibility to antimicrobial agents and less antibiotic resistance. Therefore, in this review, we aim to provide an overview of QS and biofilm formation. This review also discusses the role of natural and synthesized coumarins in controlling QS, inhibiting biofilm formation, and inducing synergy in antibiotic–coumarin combinations. Hence, this review emphasizes the potential of coumarin compounds to act as antibacterial agents and demonstrates their ability to alleviate antibiotic resistance.

23 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
EEEslam El-Sawy
Eslam El-Sawy
ZEZeinab AbdEl-khalek Elshahid
Zeinab AbdEl-khalek Elshahid
AFAhmed Abd el fatah
Ahmed Abd el fatah
ANAmr Nassrallah
Amr Nassrallah
AAAhmed B. Abdelwahab
Ahmed B. Abdelwahab
HAHeba Nabil Ali Abdelmegeed
Heba Nabil Ali Abdelmegeed
Aplysinopsins are a class of indole alkaloids that possess various pharmacological activities. Although their action has been studied in regard to many diseases, their effect on prostate cancer has not yet been examined. Therefore, we synthesized a new series of aplysinopsin analogs and investigated their cytotoxic activity against prostate cancer. Five analogs showed high antitumor activity via suppressing the expression of the anti-apoptotic gene Bcl2, simulationously increasing the expression of the pro-apoptotic genes p53, Bax and Caspase 3. The inhibition of BCL2 led to the activation of BAX, which in turn activated Caspase 3, leading to apoptosis. This dual mechanism of action via apoptosis and cell cycle arrest induction is responsible for aplysinopsin analogs antitumor activity. Hence, our newly synthesized analogs are highly promising candidates for further preclinical studies against prostate cancer.

11 April 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
AWAbeer El Wakil
Abeer El Wakil
PDPatrick Devos
Patrick Devos
HAHeba Nabil Ali Abdelmegeed
Heba Nabil Ali Abdelmegeed
AKAlaa Kamel
Alaa Kamel
Introduction: Mitochondria are essential organelles for many aspects of cellular homeostasis. They play an indispensable role in the development and progression of diseases, particularly cancer which is a major cause of death worldwide. We analyzed the scientific research output on mitochondria and cancer via PubMed and Web of Science over the period 1990–2023. Methods: Bibliometric analysis was performed by extracting data linking mitochondria to cancer pathogenesis over the period 1990–2023 from the PubMed database which has a precise and specific search engine. Only articles and reviews were considered. Since PubMed does not support analyses by countries or institutions, we utilized InCites, an analytical tool developed and marketed by Clarivate Analytics. We also used the VOSviewer software developed by the Centre for Science and Technology Studies (Bibliometric Department of Leiden University, Leiden, Netherlands), which enables us to graphically represent links between countries, authors or keywords in cluster form. Finally, we used iCite, a tool developed by the NIH (USA) to access a dashboard of bibliometrics for papers associated with a portfolio. This module can therefore be used to measure whether the research carried out is still basic, translational or clinical. Results: In total, 169,555 publications were identified in PubMed relating to ‘mitochondria’, of which 34,949 (20.61%) concerned ‘mitochondria’ and ‘dysfunction’ and 22,406 (13.21%) regarded ‘mitochondria’ and ‘cancer’. Hence, not all mitochondrial dysfunctions may lead to cancer or enhance its progression. Qualitatively, the disciplines of journals were classified into 166 categories among which cancer specialty accounts for only 4.7% of publications. Quantitatively, our analysis showed that cancer/neoplasms in the liver (2569 articles) were placed in the first position. USA occupied the first position among countries contributing the highest number of publications (5695 articles), whereas Egypt came in the thirty-eight position with 84 publications (0.46%). Importantly, USA is the first-ranked country having both the top 1% and 10% impact indicators with 207 and 1459 articles, respectively. By crossing the query ‘liver neoplasms’ (155,678) with the query ‘mitochondria’ (169,555), we identified 1336 articles in PubMed over the study period. Among these publications, research areas were classified into 65 categories with the highest percentage of documents included in biochemistry and molecular biology (28.92%), followed by oncology (23.31%). Conclusions: This study underscores the crucial yet underrepresented role of mitochondria in cancer research. Despite their significance in cancer pathogenesis, the proportion of related publications remains relatively low. Our findings highlight the need for further research to deepen our understanding of mitochondrial mechanisms in cancer, which could pave the way for new therapeutic strategies. Graphical

21 October 2025 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HAHeba Nabil Ali Abdelmegeed
Heba Nabil Ali Abdelmegeed
HAHeba Abo-Salem
Heba Abo-Salem
HSHayam A. Abd El Salam
Hayam A. Abd El Salam
EEEslam El-Sawy
Eslam El-Sawy